Roepers Is Right On Energizer

Between April and June 2012, Atlantic Investment Management reduced its position in Energizer Holdings, Inc. (NYSE:ENR) by 9% to finish the second quarter with 2.2 million shares (see more stocks Atlantic owned at the time). Apparently Atlantic’s manger, Alexander Roepers, has changed his mind: he told attendees at the Value Investing Congress that the maker of batteries, razors, and personal care products that Energizer was his top investment idea. He expects the stock to reach $100 per share in the next six months to a year, up from about $75 currently.

Alexander Roepers

Energizer Holdings, Inc.’s third fiscal quarter ended in June, with the company reporting that revenue had declined 9% compared to the same period a year ago. Earnings, however, actually edged up; the company cut advertising costs, and several costs from the previous year related to restructuring and debt retirement were no longer in effect. Combined with the effects of share buybacks, earnings per share came in at $1.06 versus 94 cents a year earlier- an increase of 13% despite the decline in sales. Over the first nine months of the fiscal year, revenue was about flat compared to the first three quarters of last year but net income was up 36% and EPS were up 45%.

However, the stock has not been very responsive to these improvements in the company’s business. It is up 10% over the last year, underperforming the S&P 500. From a quantitative perspective, it seems about fairly priced based on its current business at 15 times trailing earnings. Obviously, if the company can continue increasing earnings per share at the recent historical rate that is an excellent value for the growth. The sell-side expects an increase of only 6% in the next fiscal year, implying a forward P/E of 12. Energizer Holdings, Inc. is also now paying a dividend yield of 2.1%, and overall we would say that it has to disappoint Street expectations- which look quite achievable- in order to prove overvalued or even at its intrinsic value.

We’ve already mentioned Atlantic’s position in Energizer at the end of June, which made it the largest hedge fund holder of the stock according to our database of 13F filings. Barry Rosenstein’s JANA Partners and Charles de Vaulx’s International Value Advisers were two other funds which owned shares: they reported positions of 1.6 million and 730,000 shares, respectively. Find more stock picks from JANA Partners and from International Value Advisers.

Energizer’s peer group includes Spectrum Brands Holdings, Inc. (NYSE:SPB), whose product offerings include batteries alongside brands such as Black & Decker and George Foreman; The Procter & Gamble Company (NYSE:PG), a $190 billion market cap personal products company and owner of Duracell; Panasonic Corporation (NYSE:PC); and Avon Products, Inc. (NYSE:AVP), which is more concentrated on the personal care products side. With the exception of Panasonic- which is unprofitable on a trailing basis- all of these stocks trade at higher trailing earnings multiples than Energizer does. Panasonic is expected to recover, with analysts giving it a forward P/E of only 8, and even though we are worried about its future prospects it could be worth investigating to see what its return to profitability would look like. Avon took a severe hit to revenue and earnings last quarter versus the second quarter of 2011, and even with Wall Street analysts expecting it to bounce back its forward P/E is still 16. We don’t think it is as good a buy as Energizer. We would note that Procter & Gamble and Spectrum Brands turned in impressive earnings performances in their most recent quarter compared to a year earlier, and they are not much more expensive than Energizer on an expected earnings basis: they trade at 16 and 13 times forward estimates, respectively. With Procter & Gamble offering a 3.2% dividend yield and boasting a much larger market capitalization, it in particular may be a better buy.

What we continue to find attractive, however, is that Energizer’s relatively cheap forward P/E is based on quite modest expectations of EPS growth next year. Some of the factors that drove earnings growth last quarter, such as an end to restructuring charges, won’t be sustainable next year. Yet if the company can hold the line on revenue, or even see a very small decline, it could easily beat the Street through buybacks.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!